05 Compliance

Where zinc citrate is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-18 · Zinc Citrate

On this page
  1. The four checks, and where they apply
  2. European Union
  3. United States
  4. The contaminant table
  5. The claims boundary
  6. The document pack
  7. Before the first order

Zinc citrate sits on the permitted-form lists in the European Union and the United Kingdom, and it is sold as a dietary ingredient in the United States. Permission is only the first test. The finished product still has to meet contaminant limits, carry the supplement particulars and use only claim wording the market allows.

In one line

Permission, contaminant limits, label particulars and claim wording are four separate tests, and each market runs them on its own instruments.

The four checks, and where they apply

Permission comes from a list; purity is a ceiling on the finished supplement; labelling is a set of particulars; claims are a separate authorisation. A zinc citrate lot that meets the catalogue specification has cleared none of the four by itself. The certificate describes a powder, while the market regulates a capsule, tablet, stick or gummy, and the salt's share of the serving translates one into the other.

The United Kingdom keeps a parallel list under the Food Supplements (England) Regulations 2003, as amended by the Nutrition (Amendment) (EU Exit) Regulations 2019; zinc citrate is on it. The GB contaminant limits, retained from Regulation (EC) No 1881/2006, and the GB claims register are separate from the EU's, and Northern Ireland follows the EU list. Check legislation.gov.uk before artwork is signed.

European Union

Directive 2002/46/EC lists the vitamin and mineral substances and forms that food supplements may use. Zinc citrate appears in Part B of Annex II among the permitted zinc forms. The entry is permission, not a purity standard, and it leaves the contaminant, labelling and claim rules untouched.

Contaminants fall under Regulation (EU) 2023/915, which applies from 25 May 2023 and replaced Regulation (EC) No 1881/2006. For food supplements it sets lead at 3.0 mg/kg, cadmium at 1.0 mg/kg and mercury at 0.10 mg/kg on the product as sold. There is no harmonised EU maximum for arsenic in supplements, so a buyer must set one in the specification.

Labelling follows Regulation (EU) No 1169/2011 and the supplement particulars in Directive 2002/46/EC: the words “food supplement”, the nutrient names, the amount per portion, the percentage of the nutrient reference value, a warning not to exceed the stated daily dose, a warning to keep out of reach of children and a statement that the product is not a substitute for a varied diet. The zinc reference value is 10 mg, so the percentage is calculated against that figure. Claims are authorised in Regulation (EU) No 432/2012; a source-of-zinc claim depends on 15% of the 10 mg reference value in the daily portion, which is 1.5 mg of elemental zinc. Notification procedures and national maximum levels still differ between Member States. Check the current text before the artwork is signed.

United States

As of this review, zinc citrate is marketed in the United States as a dietary ingredient under DSHEA. The seller must show why the form is a lawful dietary ingredient: an NDI notification, a GRAS conclusion, or pre-15 October 1994 marketing evidence. The file should name the basis and hold the evidence. There is no premarket approval; the other rules still apply.

The Supplement Facts panel is set by 21 CFR 101.36. It states the amount of elemental zinc per serving and the percentage of the Daily Value, which is 11 mg for adults and children four years and older. The ingredient list names the salt, so “zinc citrate” and “zinc gluconate” are not interchangeable words on a US label even when the elemental zinc figure is the same.

A structure/function statement has to be truthful, substantiated and clear, with the DSHEA disclaimer required by 21 CFR 101.93. The marketer must notify the FDA within 30 days of first marketing a product with such a claim. A disease-related claim is not permitted. Current good manufacturing practice (21 CFR 111) also requires identity testing. There is no federal maximum level for lead in dietary supplements; California's Proposition 65 supplies a maximum allowable dose level of 0.5 µg/day and a no-significant-risk level of 15 µg/day, calculated from the daily dose.

The contaminant table

Contaminant ceilings for supplements · EU, US and UK at this review
ElementEUUSUK
Lead3.0 mg/kg in the supplement as soldNo federal supplement limit; state rules apply3.0 mg/kg retained limit
Cadmium1.0 mg/kgNo federal supplement limit1.0 mg/kg retained limit
Mercury0.10 mg/kgNo federal supplement limit0.10 mg/kg retained limit
ArsenicNo harmonised EU limitNo federal supplement limitNo harmonised GB limit

The catalogue specification for zinc citrate dihydrate is Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. For lead, cadmium and mercury those figures match the EU finished-product ceilings, but that does not make them finished-product limits. The raw material is diluted by the rest of the formula, so the calculation is the result times the salt's share of the serving, compared with the finished-product limit. A capsule has room; a stick pack that is mostly citrate has little. Set the raw-material ceiling from the finished dose.

The claims boundary

The European Union authorises zinc claims in Regulation (EU) No 432/2012. In the United States, a structure/function statement belongs to the brand and has to be truthful, substantiated and followed by the DSHEA disclaimer. No market allows a disease-related claim. This page does not reproduce claim wording, and nothing on this site is a health claim for zinc citrate: these pages publish specification, method and regulatory facts. A formulation statement such as “zinc citrate is used in capsules” describes the material, not a claim. The brand that prints a claim owns the wording and the substantiation file.

The document pack

  • Lot certificate covering zinc, citrate identity, moisture and the contaminant panel, with method, limit and result.
  • Specification and technical data sheet naming zinc citrate dihydrate and its assay basis.
  • Safety data sheet, allergen statement, GMO statement and origin record.
  • Contaminant report against the destination limits, including an arsenic limit where the buyer sets one.
  • Label artwork showing elemental zinc per portion and the % NRV or % Daily Value.
  • Claim file with the authorised wording or the US structure/function file, plus the US dietary-ingredient basis.

Before the first order

  1. Is zinc citrate a permitted zinc form in the destination market, and is the hydrate named in the specification?
  2. Do the contaminant results still sit under the finished-product limit at the real dose?
  3. Does the label state elemental zinc per portion and the correct percentage of the 10 mg EU/UK or 11 mg US reference value?
  4. Is every claim one the market authorises, in the exact wording, with the supporting file?
  5. Does the pack include the US dietary-ingredient basis and the current GB position?
  6. Does the certificate name the methods, the assay basis and the laboratory's quantification limits?

The COA page shows where the numbers sit on the certificate, the identity page covers the tests that prove the salt, and the grade page explains the hydrate and salt choice. The market summaries are in the EU, US and UK notes, and the catalogue line is on the zinc citrate product page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation